Organization Overview
Alternative names
Activated CIK with CD3-MUC1 (6 trials)
allogeneic natural killer cells (10 trials)
anti-cd3-muc1 bispecific antibody (1 trial)
autologous cytokine induced killer cells (3 trials)
autologous mesenchymal stem cells (1 trial)
autologous natural killer cells (14 trials)
bacille calmette-guerin (1 trial)
bevacizumab (avastin) (2 trials)
bifidobacterium bifidum (1 trial)
cytokine induced killer cells (2 trials)
gamma-delta t cells (9 trials)
hydroxychloroquine (plaquenil) (1 trial)
paratyphoid a and b vaccine (4 trials)
pemigatinib (Pemazyre) (1 trial)
peripheral blood mesenchymal stem cells (3 trials)
Adenocarcinoma (Phase 3)
Alzheimer Disease (Phase 4)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Atrial Fibrillation (Phase 4)
Autistic Disorder (Phase 2)
Bipolar Disorder (Phase 4)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cerebral Infarction (Phase 3)
Cerebral Small Vessel Diseases (Phase 4)
Cognitive Dysfunction (Phase 4)
Colorectal Neoplasms (Phase 2)
Compulsive Personality Disorder (Phase 2)
Dementia (Phase 4)
Dermatitis (Phase 2)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Disease (Phase 4)
Erectile Dysfunction (Phase 2)
Esophageal Neoplasms (Phase 2)
Fibrosis (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Heart Failure (Phase 3)
Heart Failure, Systolic (Phase 3)
Hepatitis (Phase 1)
Hepatitis B (Phase 1)
Hypersensitivity (Phase 4)
Infarction (Phase 4)
Inflammation (Phase 2)
Ischemia (Phase 3)
Ischemic Attack, Transient (Phase 3)
Kidney Neoplasms (Phase 2)
Laryngeal Neoplasms (Phase 2)
Leprosy (Phase 4)
Leukemia (Phase 1)
Leukemia, Myeloid (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Liver Cirrhosis (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 4)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Melanoma (Phase 2)
Menopause, Premature (Phase 2)
Myocardial Infarction (Phase 4)
Nasopharyngeal Carcinoma (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Second Primary (Phase 2)
Obsessive-Compulsive Disorder (Phase 2)
Osteoarthritis (Phase 2)
Osteoarthritis, Knee (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Pharyngeal Neoplasms (Phase 2)
Pneumonia, Pneumocystis (Phase 4)
Premature Birth (Phase 2)
Primary Ovarian Insufficiency (Phase 2)
Prostatic Neoplasms (Phase 2)
Purpura, Thrombocytopenic, Idiopathic (Phase 2)
Sarcoma (Phase 2)
Skin Diseases (Phase 4)
Skin Diseases, Vesiculobullous (Phase 4)
ST Elevation Myocardial Infarction (Phase 4)
Stomach Neoplasms (Phase 2)
Stroke (Phase 3)
Thrombocytopenia (Phase 2)
Tongue Neoplasms (Phase 2)
Tuberculosis (Phase 1)
Tuberculosis, Multidrug-Resistant (Phase 1)
Urticaria (Phase 4)
Uterine Cervical Neoplasms (Phase 2)
Vasculitis (Phase 4)
Vasculitis, Leukocytoclastic, Cutaneous (Phase 4)